PRA Group Q3 2026 Earnings: Cost Cuts Lift Efficiency as Revenue Falls

PRA Group (Nasdaq: PRAA) reported Q3 2026 revenue of $286.3 million, down about 8% from $311.1 million a year earlier, while diluted EPS improved to $0.39 from a loss of $10.43. The EPS rebound mainly reflects the absence of the prior-year $412.6 million goodwill impairment; on an adjusted basis, EPS declined to $0.39 from $0.53 as lower recovery revisions outweighed higher portfolio income and cost savings.

Core Financial Results

Portfolio income rose 5%, driven by recent purchases in Europe. However, changes in expected recoveries fell to $14.3 million from $51.4 million, reducing total portfolio revenue to $285.1 million from $309.9 million.

Adjusted operating expenses declined 6%, primarily because compensation and benefits expense fell by $8 million. Despite those savings, adjusted net income attributable to PRA decreased to $14.9 million from $20.9 million.

Adjusted operating expenses and adjusted diluted EPS are non-GAAP measures. The prior-year GAAP loss included the goodwill impairment, making the reported earnings comparison less representative of underlying operating performance.

Business and Portfolio Performance

Cash collections were mixed across markets. Europe Core was the only major collection category to post reported growth, while Europe Insolvency and other markets recorded the largest declines. On a constant-currency basis, total collections fell from $544.9 million to $535.6 million.

Management said growth in U.S. legal collections, digital collections and Europe partially offset decreases elsewhere. Europe Core collections increased about 6% on a constant-currency basis.

PRA purchased $228.7 million of nonperforming-loan portfolios, down about 10% from $255.5 million a year earlier. Europe purchases totaled approximately $129.9 million, compared with about $92.3 million in the U.S., as the company continued to limit investments to opportunities meeting its return requirements.

Estimated remaining collections reached $8.8 billion, up 5%. PRA also had an estimated $438 million of forward-flow purchase commitments for the following 12 months, comprising $247 million in the U.S., $175 million in Europe and $16 million in other markets.

Lower Recovery Revisions Offset Cost Savings

The quarter’s central issue was that expense reductions did not fully offset lower revenue from changes in expected recoveries. Total revenue declined by approximately $24.9 million, while adjusted operating expenses fell by about $13.7 million. Excluding the prior-year impairment, Q3 2025 operating profit would have been approximately $97.1 million, compared with reported operating income of $85.9 million in Q3 2026.

The decline in recovery revisions partly reflected recent work to improve cash-collection projections. This included a comprehensive portfolio review in Q2 2026 that increased Europe’s estimated remaining collections by $349 million.

Cost actions nevertheless improved adjusted cash efficiency to 63% from 61%. Compensation and benefits expense fell because of workforce reductions, organizational simplification and other PRA 3.0 initiatives. Adjusted EBITDA for the 12 months ended September 30, 2026, was $1.38 billion, up 9% according to the company.

Interest expense remained substantial at $63.8 million, little changed from the prior year. After interest and other items, income before taxes was $22.1 million, and the effective tax rate was 16%.

Funding and Balance Sheet

Cash and cash equivalents increased to $139.1 million at September 30 from $104.4 million at the end of 2025. Borrowings were $3.71 billion, compared with $3.70 billion at year-end, while total credit-facility availability was approximately $1.0 billion.

After the quarter ended, PRA issued $400 million of senior notes due in 2033. Management said the transaction extended the company’s debt maturity profile and increased funding flexibility.

Management Commentary

CEO Martin Sjolund attributed the improvement in efficiency to cost reductions and broader PRA 3.0 initiatives. Management plans to continue investing in legal collections and technology modernization while applying its targeted return requirements to portfolio purchases in what it described as a healthy supply environment.

Risks Investors Should Monitor

• Recovery-estimate sensitivity: Changes in expected recoveries declined from $51.4 million to $14.3 million. Further changes to collection forecasts could materially affect portfolio revenue and earnings.
• Uneven cash collections: Overall collections declined, with notable weakness in Europe Insolvency and other markets despite Europe Core growth.
• Interest and debt burden: Quarterly net interest expense of $63.8 million remained large relative to operating income, while borrowings stood at approximately $3.71 billion.
• Execution on cost savings and investment: PRA must preserve efficiency gains while continuing to fund legal collections and technology projects. Legal collection fees increased to $18.4 million from $16.6 million during the quarter.
• Portfolio deployment and commitments: Purchases declined year over year, and the estimated $438 million of forward-flow commitments remains dependent on seller deliveries and, in some cases, currency movements.

Summary

PRA Group’s Q3 2026 results showed better cost efficiency and continued growth in portfolio income, but lower recovery revisions and softer total collections limited underlying earnings. The main issues to monitor are whether collection trends stabilize, recovery revisions become more consistent and PRA can sustain expense discipline while investing in legal and technology capabilities.